Displaying drugs 10651 - 10675 of 12589 in total
Lersivirine
Lersivirine has been used in trials studying the treatment of HIV-1.
Investigational
Matched Description: … Lersivirine has been used in trials studying the treatment of HIV-1. …
Rusalatide acetate
Chrysalin has been used in trials studying the treatment of Radius Fracture.
Investigational
Matched Description: … Chrysalin has been used in trials studying the treatment of Radius Fracture. …
Dinitrochlorobenzene
Dinitrochlorobenzene has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Dinitrochlorobenzene has been used in trials studying the treatment of HIV Infections. …
Secoisolariciresinol
Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer. …
Talsaclidine
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … Talsaclidine has been used in trials studying the treatment of Alzheimer Disease. …
BMS-863233
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Description: … BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer. …
Tempol
Tempol has been used in trials studying the treatment of Anal Cancer.
Investigational
Matched Description: … Tempol has been used in trials studying the treatment of Anal Cancer. …
Mannose
Mannose is under investigation for the basic science of IUGR and Pregnancy.
Investigational
Matched Description: … Mannose is under investigation for the basic science of IUGR and Pregnancy. …
Merotocin
Merotocin has been used in trials studying the treatment of Preterm Delivery.
Investigational
Matched Description: … Merotocin has been used in trials studying the treatment of Preterm Delivery. …
DPCPX
CPX has been used in trials studying the treatment of Cystic Fibrosis.
Investigational
Matched Description: … CPX has been used in trials studying the treatment of Cystic Fibrosis. …
Liarozole
Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar.
Investigational
Matched Description: … Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar. …
Antimony
Antimony has been used in trials studying the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Antimony has been used in trials studying the treatment of Cutaneous Leishmaniasis. …
JNJ-38877605
JNJ-38877605 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … JNJ-38877605 has been used in trials studying the treatment of Neoplasms. …
SRT-1720
SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.
Investigational
Matched Description: … SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147] …
Edralbrutinib
Edralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.
Investigational
Matched Description: … Edralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase. …
SGN-1
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Matched Description: … SGN-1 is a genetically modified strain of _Salmonella enterica_ comprising methioninase. …
LB54640
LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
Investigational
Matched Description: … LB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor. …
CAM-101
CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.
Investigational
Matched Description: … CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen. …
TTX-siPDL1
TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Investigational
Matched Description: … TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1. …
ASP-4058
ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058.
Investigational
Matched Description: … ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058. …
PH-284
PH-284 belongs to a new family of new chemical entities called vomeropherins. Vomeropherins are self-administered by the patient with a metered nasal spray, or nasal aerosol device so that they can bind to peripheral chemosensory receptors in the nasal passages. This binding produces neural impulses that are transmitted by specific...
Investigational
Matched Description: … PH-284 is under investigation by Pherin and Organon for the treatment of anorexia nervosa, and loss of ... PH-284 belongs to a new family of new chemical entities called vomeropherins. …
INCB13739
INCB13739 is developed as a new treatment for type 2 diabetes.
It is an orally available small molecule inhibitor of 11beta-HSD1 (11-beta hydroxysteroid dehydrogenase type 1). 11beta-HSD1 is an enzyme that appears to be critical to the development of type 2 diabetes.
Investigational
Matched Description: … It is an orally available small molecule inhibitor of 11beta-HSD1 (11-beta hydroxysteroid dehydrogenase ... type 1). 11beta-HSD1 is an enzyme that appears to be critical to the development of type 2 diabetes. …
rGLP-1
rGLP-1 is a continuous infusion of glucagon-like peptide 1, or GLP-1, targeted for the treatment of congestive heart failure (CHF) in patients ineligible for transplant. GLP-1 is a naturally occurring hormone produced in the intestines in response to food intake.
Investigational
Matched Description: … rGLP-1 is a continuous infusion of glucagon-like peptide 1, or GLP-1, targeted for the treatment of congestive …
RP01
RP01 is a novel anti-IgE immunotherapy for allergic individuals. It is designed to induce the immune system to produce antibodies that block Immunoglobulin E (IgE), the key mediator of an allergic response. It could offer benefit to millions of asthma and allergy patients.
Investigational
Matched Description: … It could offer benefit to millions of asthma and allergy patients. ... induce the immune system to produce antibodies that block Immunoglobulin E (IgE), the key mediator of …
CYT007-TNFQb
CYT007-TNFQb is an active immunization therapy that aims at
providing a novel treatment to people suffering from RA or psoriasis. The vaccine should allow for administration of low
amounts of drug to individual patients (in the microgram range) and for convenient dosing schedules.
Investigational
Matched Description: … The vaccine should allow for administration of low
amounts of drug to individual patients (in the microgram …
Displaying drugs 10651 - 10675 of 12589 in total